CD36 is a receptor for oxidized high density lipoprotein: Implications for the development of atherosclerosis

FEBS Letters

Volumn 581, Issue 6, 2007, Pages 1227-1232

  Thorne, Rick F ^a,c   Mhaidat, Nizar M ^b,c   Ralston, Kylie J ^a,c   Burns, Gordon F ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NEWCASTLE MATER HOSPITAL   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; CD36; Lipoproteins; Macrophage; Oxidized HDL; Scavenger receptor

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; COPPER; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTERY INTIMA; ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID TRANSPORT; MACROPHAGE; PRIORITY JOURNAL; RECEPTOR BINDING;

ANTIGENS, CD36; ATHEROSCLEROSIS; CELL LINE, TUMOR; CELLS, CULTURED; COPPER; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION; RECEPTORS, LIPOPROTEIN; TRANSFECTION;

EID: 33847692795     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.02.043     Document Type: Article

References (36)

1. Pennings M., Meurs I., Ye D., Out R., Hoekstra M., Van Berkel T.J., and Van Eck M. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development. FEBS Lett. 580 (2006) 5588-5596
2. Krieger M. The "best" of cholesterols, the "worst" of cholesterols: a tale of two receptors. Proc. Natl. Acad. Sci. USA 95 (1998) 4077-4080
3. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272 (1997) 20963-20966
4. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268 (1993) 11811-11816
5. Acton S.L., Scherer P.E., Lodish H.F., and Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269 (1994) 21003-21009
6. Nicholson A.C., Frieda S., Pearce A., and Silverstein R.L. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines. Evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler. Thromb. Vasc. Biol. 15 (1995) 269-275
7. Kunjathoor V.V., et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
8. Moore K.J., Kunjathoor V.V., Koehn S.L., Manning J.J., Tseng A.A., Silver J.M., McKee M., and Freeman M.W. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 115 (2005) 2192-2201
9. Zhang W., Yancey P.G., Su Y.R., Babaev V.R., Zhang Y., Fazio S., and Linton M.F. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108 (2003) 2258-2263
10. Ferretti G., Bacchetti T., Negre-Salvayre A., Salvayre R., Dousset N., and Curatola G. Structural modifications of HDL and functional consequences. Atherosclerosis 184 (2006) 1-7
11. Bergt C., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA 101 (2004) 13032-13037
12. Nakajima T., et al. Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann. Clin. Biochem. 37 Pt 2 (2000) 179-186
13. Marsche G., Levak-Frank S., Quehenberger O., Heller R., Sattler W., and Malle E. Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J. 15 (2001) 1095-1097
14. La Ville A.E., Sola R., Balanya J., Turner P.R., and Masana L. In vitro oxidised HDL is recognized by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis 105 (1994) 179-189
15. Shafren D.R., Dorahy D.J., Thorne R.F., and Barry R.D. Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. J. Gen. Virol. 81 (2000) 889-894
16. Thorne R.F., Marshall J.F., Shafren D.R., Gibson P.G., Hart I.R., and Burns G.F. The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain of CD36. J. Biol. Chem. 275 (2000) 35264-35275
17. De Nichilo M.O., and Burns G.F. Macrophage colony-stimulating factor induces thrombospondin 1 production by cultured human macrophages. J. Cell Physiol. 164 (1995) 223-231
18. Banka C.L., Black A.S., Dyer C.A., and Curtiss L.K. THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets. J. Lipid Res. 32 (1991) 35-43
19. Thorne R.F., Meldrum C.J., Harris S.J., Dorahy D.J., Shafren D.R., Berndt M.C., Burns G.F., and Gibson P.G. CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells. Biochem. Biophys. Res. Commun. 240 (1997) 812-818
20. Acton S., Rigotti A., Landschulz K.T., Xu S., Hobbs H.H., and Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271 (1996) 518-520
21. Basu S.K., Goldstein J.L., Anderson R.G., and Brown M.S. Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts. Cell 24 (1981) 493-502
22. Gu X., Trigatti B., Xu S., Acton S., Babitt J., and Krieger M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J. Biol. Chem. 273 (1998) 26338-26348
23. Calvo D., Gomez-Coronado D., Suarez Y., Lasuncion M.A., and Vega M.A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39 (1998) 777-788
24. Connelly M.A., Klein S.M., Azhar S., Abumrad N.A., and Williams D.L. Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J. Biol. Chem. 274 (1999) 41-47
25. de Villiers W.J., Cai L., Webb N.R., de Beer M.C., van der Westhuyzen D.R., and de Beer F.C. CD36 does not play a direct role in HDL or LDL metabolism. J. Lipid Res. 42 (2001) 1231-1238
26. Schnitzer J.E., Oh P., Pinney E., and Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127 (1994) 1217-12132
27. Zeng Y., Tao N., Chung K.N., Heuser J.E., and Lublin D.M. Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1. J. Biol. Chem. 278 (2003) 45931-45936
28. Nieland T.J., Ehrlich M., Krieger M., and Kirchhausen T. Endocytosis is not required for the selective lipid uptake mediated by murine SR-BI. Biochim. Biophys. Acta 1734 (2005) 44-51
29. Peng Y., Akmentin W., Connelly M.A., Lund-Katz S., Phillips M.C., and Williams D.L. Scavenger receptor BI (SR-BI) clustered on microvillar extensions suggests that this plasma membrane domain is a way station for cholesterol trafficking between cells and high-density lipoprotein. Mol. Biol. Cell. 15 (2004) 384-396
30. Artola R.L., Conde C.B., Bagatolli L., Pecora R.P., Fidelio G.D., and Kivatinitz S.C. High-density lipoprotein from hypercholesterolemic animals has peroxidized lipids and oligomeric apolipoprotein A-I: its putative role in atherogenesis. Biochem. Biophys. Res. Commun. 239 (1997) 570-574
31. Liu B.W., Jiang Y., Fu M.D., Liu Y., and Fan P. Oxidative modification of lipoproteins in hypertriglyceridemic patients and hypercholesterolemic rabbits in vivo. Mol. Cell Biochem. 207 (2000) 131-135
32. Bai H., Liu B.W., Deng Z.Y., Shen T., Fang D.Z., Zhao Y.H., and Liu Y. Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Free Radic. Biol. Med. 40 (2006) 1796-1803
33. Marsche G., Zimmermann R., Horiuchi S., Tandon N.N., Sattler W., and Malle E. Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein. J. Biol. Chem. 278 (2003) 47562-47570
34. Cogny A., Paul J.L., Atger V., Soni T., and Moatti N. Structural changes of high-density-lipoprotein apolipoproteins following incubation with human polymorphonuclear cells. Eur. J. Biochem. 222 (1994) 965-973
35. Hurtado I., Fiol C., Gracia V., and Caldu P. In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis 125 (1996) 39-46
36. Levula M., Jaakkola O., Luomala M., Nikkari S.T., and Lehtimaki T. Effects of oxidized low- and high-density lipoproteins on gene expression of human macrophages. Scand. J. Clin. Lab. Invest. 66 (2006) 497-508